Submitted by Anonymous (not verified) on 29 August 2025 - 15:45
Human medicines European public assessment report (EPAR): Darzalex, daratumumab, Date of authorisation: 20/05/2016, Revision: 25, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Darzalex, daratumumab, Date of authorisation: 20/05/2016, Revision: 25, Status: Authorised